Product Description
TCS HDAC6 20b is an inhibitor of histone deacetylase 6 (HDAC6). It synergistically inhibits the growth of HCT116 cells at a concentration of 5 µM in combination with paclitaxel. It blocks the growth of estrogen receptor α-positive breast cancer MCF-7 cells treated with estrogen.
TCS HDAC6 20b is an inhibitor of histone deacetylase 6 (HDAC6). It synergistically inhibits the growth of HCT116 cells at a concentration of 5 µM in combination with paclitaxel. It blocks the growth of estrogen receptor α-positive breast cancer MCF-7 cells treated with estrogen.
Biovision | B2831 | TCS HDAC6 20b DataSheet
Alternate Name/Synonyms: S-[(6S)-7-(1-adamantylamino)-6-[(2-methylpropan-2-yl)oxycarbonylamino]-7-oxoheptyl] 2-methylpropanethioate; (2S)-N-(1-Adamantyl)-2-(tert-butoxycarbonylamino)-7-(2-methylpropanoylthio)heptanamide; 2-Methylpropanethioic acid-S-[(6S)-6-[[(1,1-dimethylethoxy)carbonyl]amino]-7-oxo-7-(tricyclo[3.3.1.13,7]dec-1-ylamino)heptyl] ester
Appearance:
Formulation: Solution in ethanol
CAS Number: 956154-63-5
Structure Available?: True
Peptide sequence:
Salt Form: False
Molecular Formula: C₂₆H₄₄N₂O₄S
Molecular Weight: 480.70
Cell-Permeable?: True
Purity: ≥95%
Solubilities:
Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
Country of Origin: USA
Tag Line: An inhibitor of HDAC6
MDL Number:
PubChem CID: 23636017
SMILES: CC(C)C(=O)SCCCCCC(C(=O)NC12CC3CC(C1)CC(C3)C2)NC(=O)OC(C)(C)C
InChi: InChI=1S/C26H44N2O4S/c1-17(2)23(30)33-10-8-6-7-9-21(27-24(31)32-25(3,4)5)22(29)28-26-14-18-11-19(15-26)13-20(12-18)16-26/h17-21H,6-16H2,1-5H3,(H,27,31)(H,28,29)/t18?,19?,20?,21-,26?/m0/s1
InChi Key: DQZMLPMCOMRJOR-MOVGKWKRSA-N